Fulgent Genetics, Inc. FLGT Continuing operations (in dollars per share)
Continuing operations (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s continuing operations (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s continuing operations (in dollars per share)?
- Fulgent Genetics, Inc. (FLGT) reported continuing operations (in dollars per share) of -$0.8 in Q1 2026.
- How has Fulgent Genetics, Inc.'s continuing operations (in dollars per share) changed year-over-year?
- Fulgent Genetics, Inc.'s continuing operations (in dollars per share) decreased by 116.2% year-over-year, from -$0.37 to -$0.8.
- What is the long-term trend for Fulgent Genetics, Inc.'s continuing operations (in dollars per share)?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s continuing operations (in dollars per share) has grown at a -41.2% compound annual growth rate (CAGR), from $16.38 to -$1.96.